Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N E Davidson

Showing results (81-90 of 125) with videos related to

Pageof 13
Sort By:
Cancer Research|September 2, 2000
Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancerS J Nass, J G Herman, E Gabrielson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelinesT J Smith, N E Davidson, D V Schapira, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 18, 2007
The reliability of nipple aspirate and ductal lavage in women at increased risk for breast cancer--a potential tool for breast cancer risk assessment and biomarker evaluationK Visvanathan, D Santor, S Z Ali, et al.
Cancer Chemotherapy and Pharmacology|May 13, 1999
A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancerS Subramanyan, M D Abeloff, S E Bond, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2001
Combination of standard cytotoxic agents with polyamine analogues in the treatment of breast cancer cell linesH A Hahm, V R Dunn, K A Butash, et al.
Cancer|March 26, 1999
Long term follow-up of women treated with 16-week, dose-intensive adjuvant chemotherapy for high risk breast carcinomaB Mikhak, M Zahurak, M D Abeloff, et al.
Cancer Research|October 15, 1995
Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancersJ G Herman, A Merlo, L Mao, et al.
The Journal of Clinical Investigation|June 1, 1990
v-rasH induces non-small cell phenotype, with associated growth factors and receptors, in a small cell lung cancer cell lineJ P Falco, S B Baylin, R Lupu, et al.
JAMA|August 17, 1994
Estrogen replacement therapy in breast cancer survivors. A time for change. Breast Cancer Committees of the Eastern Cooperative Oncology GroupM A Cobleigh, R F Berris, T Bush, et al.
Cancer Research|January 13, 2001
Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibitionX Yang, A T Ferguson, S J Nass, et al.
Pageof 13

Showing results (81-90 of 125) with videos related to

Sort By:
Pageof 13
Cancer Research|September 2, 2000
Aberrant methylation of the estrogen receptor and E-cadherin 5' CpG islands increases with malignant progression in human breast cancerS J Nass, J G Herman, E Gabrielson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
American Society of Clinical Oncology 1998 update of recommended breast cancer surveillance guidelinesT J Smith, N E Davidson, D V Schapira, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 18, 2007
The reliability of nipple aspirate and ductal lavage in women at increased risk for breast cancer--a potential tool for breast cancer risk assessment and biomarker evaluationK Visvanathan, D Santor, S Z Ali, et al.
Cancer Chemotherapy and Pharmacology|May 13, 1999
A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancerS Subramanyan, M D Abeloff, S E Bond, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 10, 2001
Combination of standard cytotoxic agents with polyamine analogues in the treatment of breast cancer cell linesH A Hahm, V R Dunn, K A Butash, et al.
Cancer|March 26, 1999
Long term follow-up of women treated with 16-week, dose-intensive adjuvant chemotherapy for high risk breast carcinomaB Mikhak, M Zahurak, M D Abeloff, et al.
Cancer Research|October 15, 1995
Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancersJ G Herman, A Merlo, L Mao, et al.
The Journal of Clinical Investigation|June 1, 1990
v-rasH induces non-small cell phenotype, with associated growth factors and receptors, in a small cell lung cancer cell lineJ P Falco, S B Baylin, R Lupu, et al.
JAMA|August 17, 1994
Estrogen replacement therapy in breast cancer survivors. A time for change. Breast Cancer Committees of the Eastern Cooperative Oncology GroupM A Cobleigh, R F Berris, T Bush, et al.
Cancer Research|January 13, 2001
Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibitionX Yang, A T Ferguson, S J Nass, et al.
Pageof 13